Kamis 03 Dec 2015 18:41 WIB

Warsito research on cancer device forcefully stopped by government

Rep: C09/ Red: Julkifli Marbun
illustration
Foto: Republika/Mardiah
illustration

REPUBLIKA.CO.ID, JAKARTA -- The development of research conducted by Warsito Purwo Taruno must be stopped by the government through Health Research and Development Agency, Ministry of Health. According to Warsito, the license revocation was done because his research was considered not scientifically-based.

Warsito said, Health Research and Development Agency was a 'Father' in his research. Because of the government agency, he could begin the research and generate the finding. Knowing the government has issued license revocation on his study, Warsito was surprised.

"I was like children who was expelled by his father," said Warsito to Republika, Tuesday (1/12).

Warsito Purwo Taruno was the 8th recipient of BJ Habibie Technology Award (BJHTA). This award was given to him because of the finding of Electrical Capacitance Tomography Volume (ECTV). He said, ECTV is a detection of brain and breast cancer.

"This tool utilizes wasted energy," Warsito added.

Read: Lung cancer ASEAN men top killer

Warsito admitted his technology development was still considered controversial in medical world because the device uses static wave. While, other development of technologies generally use primary wave. According to Warsito, the static wave turned out to have a pretty good benefits.

He argued, this waveform contains a lot of information that can be extracted. Then the information can be digitized into the computer. In general, he added, the development of technology with primary wave will require enormous energy, ie up to 200 volts. Meanwhile, static wave only requires low energy.

The discovery of this technology has been through a long process. He explained, the finding have yielded results around 78 percent

"It means, 78 percent of users of the device managed to survive from brain or breast cancer," he said.

One derivative of ECTV technology is an application for cancer therapy, namely Electro-Capacitive Cancer Therapy (ECCT). This application has been registered in 2012.

According to Warsito, ECCT and ECTV are similar to radiotherapy for treatment or CT scan with ionizing electromagnetic waves. The difference, he added, ECTV and ECCT utilize basic characteristic of biophysical of cells and tissues.

ECTV and ECCT obviously give great hope for cancer therapy based on non-radiative energy waves. For instance, cancer in the brain stem may still be 'cleaned' by ECCT. Warsito recognized that ECVT and ECCT have no references in the world. This was because both technologies were born in Indonesia and were the first in the world.

Advertisement
Berita Lainnya
Advertisement
Most Read
Advertisement
Advertisement